DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pemetrexed
Pemetrexed
Pemetrexed-Lilly-Epar-Product-Information En.Pdf
Pemetrexed (Alimta) Is Covered Pemetrexed (Alimta®) Is Considered Medically Necessary for the Treatment of Patients With
Original Article Pemetrexed and Cyclophosphamide Combination Therapy for the Treatment of Non-Small Cell Lung Cancer
A Preclinical Evaluation of Pemetrexed and Irinotecan Combination As Second-Line Chemotherapy in Pancreatic Cancer
Cancer Drug Pharmacology Table
BC Cancer Benefit Drug List September 2021
Arsenic Trioxide Targets MTHFD1 and SUMO-Dependent Nuclear De Novo Thymidylate Biosynthesis
The Value of Pemetrexed for the Treatment of Malignant Pleural Mesothelioma: a Comprehensive Review CHRISTEL C.L.M
82804218.Pdf
The Role of Folate Receptor Alpha (Fra) in the Response of Malignant Pleural Mesothelioma to Pemetrexed-Containing Chemotherapy
Phase II Study of the Efficacy and Safety of High-Dose Pemetrexed in Combination with Cisplatin Versus Temozolomide for the Trea
Pemetrexed (Alimta®)
Summary of Clinical Trial Results for Laypersons
Lecture 3: Antimetabolites – Cell Cycle Specific (S-Phase) 1. Folate Analogs
21-462/S-015
CHMP Agenda of the 18-21 April 2017 Meeting
For Health Professionals Who Care for Cancer Patients
Product List 2019 Finished Dosage Forms (Partner Label), Active Pharmaceutical Ingredients
Top View
Lists of Medicinal Products for Rare Diseases in Europe*
Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy
Cancer Drug Costs for a Month of Treatment at Initial Food
Appendix B - Product Name Sorted by Applicant
Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
Phase I and Pharmacokinetic Study of Pemetrexed Plus Cisplatin In
Defining Risks of Taxane Neuropathy: Insights from Randomized Clinical Trials
Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
Clinical Option of Pemetrexed-Based Versus
Pemetrexed (Alimta®, Pemfexytm)
ALIMTA Safely and Effectively
How to Order Chemotherapy at Shands at the University of Florida - Inpatient
ALIMTA Safely and Effectively
Phase II Study of Pemetrexed-Gemcitabine Combination in Patients with Advanced-Stage Non-Small Cell Lung Cancer
Outpatient Cancer Drug Benefit Program List
Emetogenic Potential of Antineoplastic Agents
LUNG CANCER TREATMENT REGIMENS (Part 1 of 7) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
Non-Small Cell (Nsclc)
NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014
Pemetrexed Combined with Oxaliplatin Or Carboplatin As First-Line Treatment in Advanced Non–Small Cell Lung Cancer: a Multicenter, Randomized, Phase II Trial
New Zealand Data Sheet Pemetrexed Accord
Regimen Reference Order – THOR – Pemetrexed + Cisplatin
2 Combinations of Antimetabolites and Ionizing Radiation
Orange Book Cumulative Supplement 7 July 2021
Alimta, INN-Pemetrexed
Emetic Risk of Single Intravenous Antineoplastic Agents in Adults
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
A Phase I Study of Pemetrexed, Carboplatin, and Concurrent
Pemetrexed (Alimta) Reference Number: CP.PHAR.368 Effective Date: 10.31.17 Last Review Date: 02.18 Coding Implications Line of Business: Medicaid Revision Log
ANTI-METABOLITES Folate Antagonists: MTX, Pemetrexed
Evaluation of Arsenic Trioxide Potential for Lung Cancer
Sequence-Dependent Administration of Raloxifene and 5-Fluorouracil/Pemetrexed Protects Against Pemetrexed Cytotoxicity in Human Bone Marrow
DRUG NAME: Pemetrexed
And Cyclophosphamide in Patients With
• on September 24, the Food and Drug Administration (FDA
Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid
Pemetrexed in Malignant Pleural Mesothelioma
Committee for Medicinal Products for Human Use (CHMP) Minutes of the Meeting on 20-23 March 2017
Downregulation of Thymidylate Synthase and E2F1 by Arsenic Trioxide in Mesothelioma
BC Cancer Protocol Summary for First-Line Treatment of Advanced Non-Small Cell Lung Cancer with Platinum and Pemetrexed
Hazardous Drug List
The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer
Overview of Dual-Acting Drug Methotrexate in Different
NCT Number: NCT01675765